Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI

NCT02651350 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Drug-induced Liver Injury,Chronic

Interventions

DRUG: Methylprednisolone
DRUG: Standard Treatment

Sponsor

Beijing 302 Hospital